Detrimental benefits usually do not rule out SARS-CoV-2 infection and should not be utilized as the only foundation for treatment method or patient management choices, like an infection Manage decisions. Be sure to see FDA advice  on the use of at-property COVID-19 antigen tests. Addition of health fairness factors relevant to testing, such a